OneMedNet Corp (ONMD) IPO - S-1 Filing, Stock & Insider Activity
OneMedNet Corp IPO - Status & S-1 Filing
- Ticker: ONMD
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-07-01
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- SEC CIK: 0001849380 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
OneMedNet Corp (ONMD) has filed 6 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-24. Insiders disclosed 7 open-market purchases totaling $602K. 2 Form 8-K material event filings were reported by ONMD in the last 90 days. InsiderAlpha tracks every ONMD SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About OneMedNet Corp (ONMD)
OneMedNet Corp trades under the ticker ONMD. InsiderAlpha tracks 19 primary SEC Form 4 filings from 9 reporting insiders for ONMD since 2025, sourced directly from SEC EDGAR.
| SEC CIK | 0001849380 |
|---|
90-Day SEC Filing Activity
| Insider purchases (90d) | 7 ($602K) |
|---|---|
| Form 4 filings (90d) | 6 |
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-24 |
Recent ONMD Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jeffrey Yu | Chief Medical Officer | P - Open-market purchase | 158.7K | $0.63 | $100K | SEC | |
| Aaron Green | Chief Executive Officer | P - Open-market purchase | 36.6K | $0.57 | $21K | SEC | |
| Jeffrey Yu | Chief Medical Officer | P - Open-market purchase | 172.4K | $0.58 | $100K | SEC | |
| Aaron Green | Chief Executive Officer | P - Open-market purchase | 18.7K | $0.54 | $10K | SEC | |
| Aaron Green | Chief Executive Officer | P - Open-market purchase | 36.9K | $0.56 | $21K | SEC | |
| Thomas Kosasa | Director | P - Open-market purchase | 158.7K | $0.63 | $100K | SEC | |
| Thomas Kosasa | Director | P - Open-market purchase | 268.8K | $0.93 | $250K | SEC | |
| Thomas Kosasa | Director | P - Open-market purchase | 280.9K | $0.89 | $250K | SEC | |
| Jeffrey Yu | Chief Medical Officer | P - Open-market purchase | 903.6K | $0.83 | $750K | SEC | |
| Jeffrey Yu | Chief Medical Officer | A - Grant or award | 219.4K | $0.83 | $182K | SEC | |
| Thomas Kosasa | Director | P - Open-market purchase | 595.2K | $0.84 | $500K | SEC | |
| Jair Clarke | Director | A - Grant or award | 45.0K | $0.00 | - | SEC | |
| Eric Casaburi | Director | A - Grant or award | 45.0K | $0.00 | - | SEC | |
| Kenneth Alleyne | Director | A - Grant or award | 38.2K | $0.00 | - | SEC | |
| Sherry Coonse McCraw | Director | A - Grant or award | 45.0K | $0.00 | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for OneMedNet Corp (ONMD). Updated in real time as new filings are submitted to the SEC.
Most-Active ONMD Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Aaron Green | 3 | $52K |
| Jeffrey Yu | 2 | $200K |
| Thomas Kosasa | 2 | $350K |
Recent ONMD Form 8-K Material Events
- - Item 5.08, 8.01 [SEC]
- - Item 1.01, 9.01 [SEC]
- - Item 3.01 · Restructuring · negative [SEC]
OneMedNet Corporation received notice from Nasdaq on April 14, 2026, that it is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company has 180 calendar days (until October 12, 2026) to regain compliance by ac
Recent Insider Filings
- - Aaron Green (Chief Executive Officer)
- - Jeffrey Yu (Chief Medical Officer)
- - Jeffrey Yu (Chief Medical Officer)
- - Aaron Green (Chief Executive Officer)
- - Thomas Kosasa (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ONMD insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
ONMD Insider Trading - FAQ
- What is the latest insider trade for ONMD?
- OneMedNet Corp (ONMD) had 6 insider filings in the last 90 days, with the most recent on 2026-06-24. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying ONMD stock?
- 7 insider purchases of ONMD were filed in the last 90 days, totaling $602K.
- How many insiders are selling ONMD stock?
- 0 insider sales of ONMD were filed in the last 90 days.
- Where can I see ONMD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks ONMD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $OPTH Optimi Health Corp.
- $OPTN Option Therapeutics Inc.
- $ORIS ORIENTAL RISE HOLDINGS Ltd
- $OSPR Osprey Acquisition Corp. III
- $OTAI Starlink AI Acquisition Corp
- $OWLS OBOOK HOLDINGS INC.
- $OXLC Oxford Lane Capital Corp.
- $OZSC OZOP ENERGY SOLUTIONS, INC.
- $PAAC Proem Acquisition Corp. I
- $PALO PALOMA ACQUISITION CORP I
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live ONMD dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.